million 11.18 2. The operation results (from the consolidated financial statements) ended March 31 Item First quarter of 2018 First quarter of 2017 Profit for three months attributable to equity holders of
source of the Company’s revenue. Despite such impediments, the Company recognized the growth potential from the followings: 1) Increased revenue and profit from new business investment which are: “Elite
151 66 -50% -56% 529 692 31% Natural Resource Business Group 5/ 16 (81) 94 470% 216% 286 117 -59% Others 6/ (24) (61) (92) (137) (282) Profit attributable to owners of the Company 1,471 1,856 (1,546
DCON PRODUCTS PUBLIC Co.,Ltd. and Subsidiaries Company Management’s Discussion and Analysis (MD&A) For the Year 2019 1. Revenue,Gross Profit & Net Profit Unit :M.Bht Year 2019 Year 2018 Year 2017 1
profit margin was slightly brought down by 0.9% of gross profit margin due to turnaround costs and the rise of main raw material prices from tight supply plus greater crude oil prices. 2. In Q2 2018
source of the Company’s revenue. Despite such impediments, the Company recognized the growth potential from the followings: 1) Increased revenue and profit from new business investment which are: “Elite
source of the Company’s revenue. Despite such impediments, the Company recognized the growth potential from the followings: 1) Increased revenue and profit from new business investment which are: “Elite
person as following details: Borrower Mana Patanakarn Company Limited as a subsidiary of Nawarat Patanakarn Public Company Limited which 100% share holding Lender 1. K Alliance Company Limited 2. Mrs
Mrs. Siriya Thepcharoen Mrs. Siriya Thepcharoen, Chief Executive Officer who is responsible for the operation of World Medical Alliance (Thailand) Company Limited (WMA) shall be liable for WMA's
-113.3% Financial expenses -0.66 -1.16 0.50 -43.1% Share of income from investment in associate 0.09 0.52 -0.43 -82.7% Income tax expenses 0.82 -6.58 7.40 -112.5% Net profit for the period -4.40 27.71